Matthew B Murphy's most recent trade in Nautilus Biotechnology Inc was a trade of 20,000 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Sept. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nautilus Biotechnology Inc | Matthew B. Murphy | General Counsel | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 04 Sep 2025 | 20,000 | 74,140 | - | 0.6 | 12,858 | Common Stock |
| Nautilus Biotechnology Inc | Matthew B. Murphy | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | |
| Nautilus Biotechnology Inc | Matthew B. Murphy | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) |